167 related articles for article (PubMed ID: 6971114)
1. Some pharmacokinetic properties and bioavailability by oral and rectal route of piroxicam in rodents and in man.
Schiantarelli P; Acerbi D; Bovis G
Arzneimittelforschung; 1981; 31(1):92-7. PubMed ID: 6971114
[TBL] [Abstract][Full Text] [Related]
2. Piroxicam pharmacologic activity and gastrointestinal damage by oral and rectal route. Comparison with oral indometacin and phenylbutazone.
Schiantarelli P; Cadel S
Arzneimittelforschung; 1981; 31(1):87-92. PubMed ID: 6971112
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and drug input characteristics for a diclofenac-codeine phosphate combination following oral and rectal administration.
Hanses A; Spahn-Langguth H; Meiss F; Mutschler E
Arzneimittelforschung; 1996 Jan; 46(1):57-63. PubMed ID: 8821519
[TBL] [Abstract][Full Text] [Related]
5. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetic evaluation of compressed suppositories of diclofenac sodium in humans.
Ramakrishna S; Fadnavis NW; Diwan PV
Arzneimittelforschung; 1996 Feb; 46(2):175-7. PubMed ID: 8720309
[TBL] [Abstract][Full Text] [Related]
7. [Studies on pharmacokinetics and biotransformation of reproterol in animal and man (author's transl)].
Niebch G; Obermeier K; Vergin H; Thiemer K
Arzneimittelforschung; 1977; 27(12):37-45. PubMed ID: 576829
[TBL] [Abstract][Full Text] [Related]
8. Disposition of abouthiouzine: a novel antihyperthyroid drug.
Alkharfy KM; Khan RM; Al-Hadiya BM; Abou-Auda HS; Abou-Shaaban RR
Biopharm Drug Dispos; 2007 Apr; 28(3):105-11. PubMed ID: 17230598
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetic and biopharmaceutic study of chloracetadol administered by the intravenous and rectal routes in rabbits].
Montserrat M; Obach R; Martin A; Domenech J
Ann Pharm Fr; 1982; 40(4):365-72. PubMed ID: 6984305
[No Abstract] [Full Text] [Related]
10. Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetate.
Jia L; Coward LC; Kerstner-Wood CD; Cork RL; Gorman GS; Noker PE; Kitada S; Pellecchia M; Reed JC
Cancer Chemother Pharmacol; 2008 Jan; 61(1):63-73. PubMed ID: 17356822
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
12. Absolute bioavailability of paracetamol after oral or rectal administration in healthy volunteers.
Eandi M; Viano I; Ricci Gamalero S
Arzneimittelforschung; 1984; 34(8):903-7. PubMed ID: 6548636
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
[TBL] [Abstract][Full Text] [Related]
14. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
15. The effect of activated charcoal on the bioavailability of piroxicam in man.
Laufen H; Leitold M
Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):48-52. PubMed ID: 3957490
[TBL] [Abstract][Full Text] [Related]
16. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of lornoxicam in man.
Hitzenberger G; Radhofer-Welte S; Takacs F; Rosenow D
Postgrad Med J; 1990; 66 Suppl 4():S22-7. PubMed ID: 2284217
[TBL] [Abstract][Full Text] [Related]
18. Disposition of remoxipride in different species. Species differences in metabolism.
Widman M; Nilsson LB; Bryske B; Lundström J
Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
[TBL] [Abstract][Full Text] [Related]
19. Metabolic fate of exogenous chondroitin sulfate in man.
Conte A; de Bernardi M; Palmieri L; Lualdi P; Mautone G; Ronca G
Arzneimittelforschung; 1991 Jul; 41(7):768-72. PubMed ID: 1772467
[TBL] [Abstract][Full Text] [Related]
20. The rabbit as an experimental model for biopharmaceutical studies following rectal administration of theophylline.
Van Aerde P; Moerman E; Van Severen R; Braeckman P
Pharmazie; 1984 Mar; 39(3):171-2. PubMed ID: 6728890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
